Information on this Web site is provided as is without warranty of any kind, either express or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or noninfringement. Some jurisdictions do not allow the exclusion of implied warranties, so the above exclusion may not apply to you. The data set forth herein are for informational purposes only, and no warranty is made that the information is error-free. Information provided on this Web site is not a substitute for the advice of a medical professional. Please note that once you leave this site, either by using a link we may have provided for your convenience or by specifying your own destination, Promius® Pharma accepts no responsibility for the content, products, and/or services provided at these non–Promius Pharma locations. Promius Pharma does not control, endorse, promote, or have any affiliation with any other Web site unless expressly stated herein.
IN NO EVENT WILL PROMIUS PHARMA BE LIABLE TO ANY PARTY FOR ANY DIRECT, INDIRECT, SPECIAL, OR OTHER CONSEQUENTIAL DAMAGES ARISING OUT OF ANY USE OF THIS WEB SITE, OR ANY OTHER HYPERLINKED WEB SITE, INCLUDING, WITHOUT LIMITATION, ANY LOST PROFITS, BUSINESS INTERRUPTION, LOSS OF PROGRAMS OR DATA ON YOUR EQUIPMENT, OR OTHERWISE, EVEN IF WE ARE EXPRESSLY ADVISED OF THE POSSIBILITY OR LIKELIHOOD OF SUCH DAMAGES.
Information may be changed or updated without notice. Promius Pharma has no obligation to update information presented on this Web site, so information contained herein may be out of date at any given time. Promius Pharma may also make improvements and/or changes in the products and/or programs described in this information at any time without notice.
INDICATION AND IMPORTANT SAFETY INFORMATION
Trianex® 0.05% (Triamcinolone Acetonide Ointment, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The most common adverse events with Trianex Ointment include burning, itching, irritation, dryness, and folliculitis. Trianex Ointment is contraindicated in patients who are hypersensitive to any of the ingredients of this product. As with all topical corticosteroids, systemic absorption can produce reversible HPA-axis suppression.
Please See Full Prescribing Information.
Trianex is a registered trademark of CMP Pharma, Inc. ©2015 Promius Pharma, LLC. All rights reserved.